MRDC FAMILY
DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
Contact Us
|
Site Map
Transforming Health Care through Innovative and Impactful Research
Submit
Toggle navigation
Home
(current)
Research Programs
Alcohol and Substance Use Disorders
Amyotrophic Lateral Sclerosis
Arthritis
Autism
Bone Marrow Failure
Breast Cancer
Chronic Pain Management
Combat Readiness-Medical
Duchenne Muscular Dystrophy
Epilepsy
Glioblastoma
Gulf War Illness
Hearing Restoration
Joint Warfighter Medical
Kidney Cancer
Lung Cancer
Lupus
Melanoma
Military Burn
Multiple Sclerosis
Neurofibromatosis
Neurotoxin Exposure Treatment Parkinson's
Orthotics and Prosthetics Outcomes
Ovarian Cancer
Pancreatic Cancer
Parkinson's
Peer Reviewed Alzheimer's
Peer Reviewed Cancer
Peer Reviewed Medical
Peer Reviewed Orthopaedic
Prostate Cancer
Rare Cancers
Reconstructive Transplant Research
Scleroderma
Spinal Cord Injury
Tick-Borne Disease
Toxic Exposures
Traumatic Brain Injury and Psychological Health
Tuberous Sclerosis Complex
Vision
Additional Supported DOD Programs/Projects
Defense Medical Research and Development
Medical Simulation and Information Sciences Research Program (JPC-1)
Military Infectious Diseases Research Program (JPC-2)
Military Operational Medicine Research Program (JPC-5)
Combat Casualty Care Research Program (JPC-6)
Radiation Health Effects Research Program (JPC-7)
Clinical and Rehabilitative Medicine Research Program (JPC-8)
Psychological Health/Traumatic Brain Injury
Previously Funded Research Programs
Funding Opportunities
Program Funding Opportunities
Start Pre-Application (eBRAP)
How To Apply
Avoiding Research Duplication
Program Funding Opportunities Archives
Webinar Series
Consumers
Eligibility Checklist
Program Consumer Reviewer Requirements
Consumer Experiences
Frequently Asked Questions
Consumer Nomination Application
How You are Evaluated
Search Awards & Publications
About Us
CDMRP
About Us
Leadership
Press Releases
Program Booklets
Research Resources
Contact Us
Funding
Funding Process
Funding History
Annual Reports
Webinar Series
Review
Two Tiered Review Process
Home
Research Programs
Multiple Sclerosis
Research Highlights
2024 Multiple Sclerosis Research Highlights
Multiple Sclerosis
2024 Multiple Sclerosis Research Highlights
Glucagon-Like Peptide-1 Receptor Agonist as New Therapeutics for Multiple Sclerosis
